Medplus Health Services Ltd

Medplus Health Services Ltd has filed disclosures regarding the encumbrance of shares by its promoters, Agilemed Investments Private Limited, Lone Furrow Investments Private Limited, and Madhukar Reddy Gangadi. A significant portion of the promoter shareholding, 72.96%, is currently encumbered. The disclosures detail various encumbrance events, including pledges and liens, with specific dates of creation and release, and the entities in whose favor these encumbrances were made, such as Catalyst Trusteeship Limited acting as Debenture Trustee for different Debenture Holders.

Agilemed Investments Private Limited, a promoter of Medplus Health Services Limited, has created additional pledges over 5,50,000 equity shares. This action, taken on September 30, 2026, is to maintain the Security Cover Ratio required under existing Share Pledge Agreements for Non-Convertible Debentures held by Modulus Alternatives Investment Managers Limited and Neo debenture holders. No new funds were borrowed. Following this, Agilemed Investments holds a total of 1,34,27,525 equity shares of Medplus Health under pledge.

Medplus Health Services Ltd has reported the encumbrance of shares by its promoter, Agilemed Investments Private Limited. A total of 1,34,27,525 shares, representing 10.72% of the company's total share capital, have been pledged. This action was taken on September 30, 2026, as a creation of pledge. The total promoter shareholding in Medplus Health is 40.19%. The encumbered shares constitute 74.10% of the total promoter shareholding and 20% or more of the total share capital.

Medplus Health Services Ltd has received a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, from Lone Furrow Investments Pvt Ltd. This filing pertains to the creation, invocation, or release of encumbrance on promoter shares. The disclosure details specific dates, types of encumbrance (pledge, lien, etc.), and the number and percentage of shares involved for various promoters including Agilemed Investments Private Limited, Lone Furrow Investments Private Limited, and Madhukar Reddy Gangadi. A significant portion of promoter shareholding, 72.96%, is encumbered. The filing also specifies the entities in whose favor shares are encumbered, primarily related to debenture holders and debenture trustees.

Medplus Health Services Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from October 1, 2026, until 48 hours after the declaration of the company's un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors is scheduled to meet on October 27, 2026, to approve these financial results. The company will make the results available on its website and the websites of BSE and NSE.

Medplus Health Services Ltd has announced that its Board of Directors will convene on October 27, 2026. The primary agenda is to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. Concurrently, the company will implement a trading window closure for designated persons and their immediate relatives, effective from October 1, 2026, until 48 hours post the financial results declaration. The results will be disseminated on the company's website and the BSE and NSE websites.

Medplus Health Services Ltd's Board of Directors has commented on a fine levied by the Exchanges for non-compliance with SEBI LODR Regulations, 2015, specifically regarding the appointment of Mr. Ajit Pandurang Rangnekar as an independent director over 75 years of age. The Board acknowledged the non-compliance, attributing it to a bona fide interpretational difference rather than willful default. They noted that the appointment was approved by shareholders via special resolution at the AGM on August 17, 2026. The Board has directed management to strengthen systems and processes to prevent future non-compliance.

Medplus Health Services Limited announced that its Board of Directors has approved the acquisition of the remaining 0.01% stake in its material subsidiary, Optival Health Solutions Private Limited. This acquisition, for a cash consideration of Rs. 1.10 Crore, will make Optival Health Solutions a wholly owned subsidiary of Medplus Health Services. The transaction is subject to completion of requisite documentation and formalities.

Agilemed Investments Private Limited, a promoter of Medplus Health Services Limited, has created an additional pledge of 5,00,000 equity shares. This action was taken on August 19, 2026, following a top-up notice from Catalyst Trusteeship Limited, to restore the required Security Cover Ratio under the Share Pledge Agreement. Post this creation, Agilemed Investments now holds an aggregate of 1,28,77,525 equity shares under pledge, representing 10.72% of the company's total share capital. The disclosure was made in accordance with SEBI (SAST) Regulations, 2011.

Agilemed Investments Private Limited, a promoter of Medplus Health Services Limited, has created an additional pledge of 5,00,000 equity shares. This action was taken on August 19, 2026, following a top-up notice from Catalyst Trusteeship Limited to restore the required Security Cover Ratio under the Share Pledge Agreement. Post this creation, Agilemed's total pledged shares in Medplus Health Services amount to 1,28,77,525 equity shares.